TOMA Biosciences Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 25

Employees

  • Latest Deal Type
  • M&A

TOMA Biosciences General Information

Description

Developer of cancer testing technology created to provide the sequencing system to identify clinically meaningful changes in the DNA of cancer tumors. The company's cancer testing technology provides physicians with accurate information about the errors present in a patient's tumor through their digital molecular test that identifies genomic errors in a patient's tumor and provides information that can help physicians guide treatment, enabling laboratories and researchers to uncover genomic changes in tumors.

Contact Information

Website
www.tomabio.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 242 Howard Avenue
  • Suite 242
  • Holland, MI 49424
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 242 Howard Avenue
  • Suite 242
  • Holland, MI 49424
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TOMA Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Dec-2019 Completed Generating Revenue
4. Later Stage VC (Series C1) 01-Jul-2019 Completed Generating Revenue
3. Later Stage VC (Series C) 01-Nov-2018 Completed Product Development
2. Early Stage VC (Series B) 21-Sep-2016 $11.9M $17.9M Completed Startup
1. Early Stage VC (Series A) 01-Oct-2014 $6.02M $6.02M Completed Startup
To view TOMA Biosciences’s complete valuation and funding history, request access »

TOMA Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C2
Series C1
Series B 15,500,000 $0.000010 $0.08 $1.04 $1.04 1x $1.04 14.3%
Series A 10,136,395 $0.000010 $0.06 $0.78 $0.78 1x $0.78 9.35%
To view TOMA Biosciences’s complete cap table history, request access »

TOMA Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer testing technology created to provide the sequencing system to identify clinically meaningful change
Other Pharmaceuticals and Biotechnology
Holland, MI
25 As of 2019

Aliso Viejo, CA
 

South Plainfield, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TOMA Biosciences Competitors (44)

One of TOMA Biosciences’s 44 competitors is Ambry Genetics, a Formerly PE-Backed company based in Aliso Viejo, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ambry Genetics Formerly PE-Backed Aliso Viejo, CA
Admera Health Venture Capital-Backed South Plainfield, NJ
Menarini Silicon Biosystems Formerly VC-backed Castel Maggiore, Italy
Biocept Formerly VC-backed San Diego, CA
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD
You’re viewing 5 of 44 competitors. Get the full list »

TOMA Biosciences Patents

TOMA Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019070598-A1 Library preparation for whole genome sequencing Inactive 04-Oct-2017
EP-3414693-A1 Systems and methods for analyzing nucelic acids Inactive 09-Feb-2016
EP-3414693-A4 Systems and methods for analyzing nucelic acids Inactive 09-Feb-2016
WO-2017139492-A1 Systems and methods for analyzing nucelic acids Inactive 09-Feb-2016
US-20190050530-A1 Systems and methods for analyzing nucleic acids Inactive 09-Feb-2016 G16B30/00
To view TOMA Biosciences’s complete patent history, request access »

TOMA Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TOMA Biosciences Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alafi Capital Company Venture Capital Minority
Cambridge Global Advisors Venture Capital Minority
Cantilever Investors Venture Capital Minority
Correlation Ventures Venture Capital Minority
Frontier Angels Angel Group Minority
You’re viewing 5 of 11 investors. Get the full list »

TOMA Biosciences FAQs

  • When was TOMA Biosciences founded?

    TOMA Biosciences was founded in 2013.

  • Where is TOMA Biosciences headquartered?

    TOMA Biosciences is headquartered in Holland, MI.

  • What is the size of TOMA Biosciences?

    TOMA Biosciences has 25 total employees.

  • What industry is TOMA Biosciences in?

    TOMA Biosciences’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is TOMA Biosciences a private or public company?

    TOMA Biosciences is a Private company.

  • What is TOMA Biosciences’s current revenue?

    The current revenue for TOMA Biosciences is .

  • How much funding has TOMA Biosciences raised over time?

    TOMA Biosciences has raised $26.9M.

  • Who are TOMA Biosciences’s investors?

    Alafi Capital Company, Cambridge Global Advisors, Cantilever Investors, Correlation Ventures, and Frontier Angels are 5 of 11 investors who have invested in TOMA Biosciences.

  • Who are TOMA Biosciences’s competitors?

    Ambry Genetics, Admera Health, Menarini Silicon Biosystems, Biocept, and Personal Genome Diagnostics are some of the 44 competitors of TOMA Biosciences.

  • When was TOMA Biosciences acquired?

    TOMA Biosciences was acquired on 01-Dec-2019.

  • Who acquired TOMA Biosciences?

    TOMA Biosciences was acquired by Trident Labs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process